Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes.
Karl VazDaniel Clayton-ChubbAmmar MajeedJohn LubelDavid SimmonsWilliam KempStuart K RobertsPublished in: Hepatology international (2023)
MAFLD prevalence is higher than NAFLD prevalence, carries a higher risk of overall mortality, with greater granularity in risk-stratification amongst MAFLD subtypes.